Breast Invasive Ductal Carcinoma (IDC): Triple-negative / basal-like (ER–/PR–/HER2–)

The most common invasive breast cancer. Biology-driven care hinges on ER/PR, HER2, Ki-67, nodal status, stage, and genomic assays.

• Back to Breast Invasive Ductal Carcinoma (IDC) overview
• Breast Invasive Ductal Carcinoma (IDC): Luminal A–like
• Breast Invasive Ductal Carcinoma (IDC): Luminal B–like
• Breast Invasive Ductal Carcinoma (IDC): HER2-enriched
• Breast Invasive Ductal Carcinoma (IDC): Triple-negative (basal-like)